메뉴 건너뛰기




Volumn 17, Issue 3, 2012, Pages 242-266

Pharmacogenetics of antipsychotic-induced weight gain: Review and clinical implications

Author keywords

antipsychotics; genetics; personalized medicine; pharmacogenetics; schizophrenia; weight gain

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; DEXFENFLURAMINE; ENDOCANNABINOID; FLUPHENAZINE; GHRELIN; HALOPERIDOL; HIGH DENSITY LIPOPROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; NEUROLEPTIC AGENT; NEUROPEPTIDE Y; NEUROTROPHIC FACTOR; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SEROTONIN 1 RECEPTOR; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TRIFLUOPERAZINE; TUMOR NECROSIS FACTOR ALPHA; ZIPRASIDONE;

EID: 84857356940     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.109     Document Type: Review
Times cited : (209)

References (165)
  • 1
    • 77950456771 scopus 로고    scopus 로고
    • Antipsychotics and schizophrenia: From efficacy and effectiveness to clinical decision-making
    • Foussias G, Remington G. Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-making. Can J Psychiatry 2010; 55: 117-125.
    • (2010) Can J Psychiatry , vol.55 , pp. 117-125
    • Foussias, G.1    Remington, G.2
  • 2
    • 0024264554 scopus 로고
    • The role of neuroleptics in manic-depressive illness
    • Kane JM. The role of neuroleptics in manic-depressive illness. J Clin Psychiatry 1988; 49(Suppl): 12-14.
    • (1988) J Clin Psychiatry , vol.49 , Issue.SUPPL. , pp. 12-14
    • Kane, J.M.1
  • 3
    • 78049503930 scopus 로고    scopus 로고
    • Pharmacologic treatment of schizophrenia
    • Kane JM, Correll CU. Pharmacologic treatment of schizophrenia. Dialogues Clin Neurosci 2010; 12: 345-357.
    • (2010) Dialogues Clin Neurosci , vol.12 , pp. 345-357
    • Kane, J.M.1    Correll, C.U.2
  • 4
    • 33748998982 scopus 로고    scopus 로고
    • Genetics of antipsychotic treatment emergent weight gain in schizophrenia
    • DOI 10.2217/14622416.7.6.863
    • Müller DJ, Kennedy JL. Genetics of antipsychotic treatment emergent weight gain in schizophrenia. Pharmacogenomics 2006; 7: 863-887. (Pubitemid 44446736)
    • (2006) Pharmacogenomics , vol.7 , Issue.6 , pp. 863-887
    • Muller, D.J.1    Kennedy, J.L.2
  • 5
    • 0842285539 scopus 로고    scopus 로고
    • Pharmacogenetics of antipsychotic-induced weight gain
    • DOI 10.1016/j.phrs.2003.05.001
    • Müller DJ, Muglia P, Fortune T, Kennedy JL. Pharmacogenetics of antipsychotic-induced weight gain. Pharmacol Res 2004; 49: 309-329. (Pubitemid 38175329)
    • (2004) Pharmacological Research , vol.49 , Issue.4 , pp. 309-329
    • Muller, D.J.1    Muglia, P.2    Fortune, T.3    Kennedy, J.L.4
  • 6
    • 75749148791 scopus 로고    scopus 로고
    • Pharmacogenetics of antipsychoticinduced side effects
    • Lencz T, Malhotra AK. Pharmacogenetics of antipsychoticinduced side effects. Dialogues Clin Neurosci 2009; 11: 405-415.
    • (2009) Dialogues Clin Neurosci , vol.11 , pp. 405-415
    • Lencz, T.1    Malhotra, A.K.2
  • 7
    • 7044247503 scopus 로고    scopus 로고
    • Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain
    • DOI 10.1016/j.jpsychires.2004.04.012, PII S0022395604000573
    • Himmerich H, Kaufmann C, Schuld A, Pollmacher T. Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain. J Psychiatr Res 2005; 39: 35-42. (Pubitemid 39422284)
    • (2005) Journal of Psychiatric Research , vol.39 , Issue.1 , pp. 35-42
    • Himmerich, H.1    Kaufmann, C.2    Schuld, A.3    Pollmacher, T.4
  • 8
    • 33846975815 scopus 로고    scopus 로고
    • Metabolic considerations in the use of antipsychotic medications: A review of recent evidence
    • Newcomer JW. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 2007; 68(Suppl 1): 20-27.
    • (2007) J Clin Psychiatry , vol.68 , Issue.SUPPL. 1 , pp. 20-27
    • Newcomer, J.W.1
  • 10
    • 16644374783 scopus 로고    scopus 로고
    • Schizophrenia and obesity: Impact of antipsychotic medications
    • Wirshing DA. Schizophrenia and obesity: impact of antipsychotic medications. J Clin Psychiatry 2004; 65(Suppl 18): 13-26.
    • (2004) J Clin Psychiatry , vol.65 , Issue.SUPPL. 18 , pp. 13-26
    • Wirshing, D.A.1
  • 11
    • 0024466603 scopus 로고
    • Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values
    • Meltzer HY, Matsubara S, Lee JC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 1989; 251: 238-246.
    • (1989) J Pharmacol Exp Ther , vol.251 , pp. 238-246
    • Meltzer, H.Y.1    Matsubara, S.2    Lee, J.C.3
  • 12
    • 37249034101 scopus 로고    scopus 로고
    • Atypical antipsychotic-induced metabolic side effects: Insights from receptor-binding profiles
    • DOI 10.1038/sj.mp.4002066, PII 4002066
    • Nasrallah HA. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry 2008; 13: 27-35. (Pubitemid 350275185)
    • (2008) Molecular Psychiatry , vol.13 , Issue.1 , pp. 27-35
    • Nasrallah, H.A.1
  • 13
    • 0035120410 scopus 로고    scopus 로고
    • Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia
    • DOI 10.1146/annurev.med.52.1.503
    • Kapur S, Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Ann Rev Med 2001; 52: 503-517. (Pubitemid 32195338)
    • (2001) Annual Review of Medicine , vol.52 , pp. 503-517
    • Kapur, S.1    Remington, G.2
  • 14
    • 0035094264 scopus 로고    scopus 로고
    • 2 receptor explain the action of atypical antipsychotics?: A new hypothesis
    • DOI 10.1176/appi.ajp.158.3.360
    • Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis. Am J Psychiatry 2001; 158: 360-369. (Pubitemid 32205190)
    • (2001) American Journal of Psychiatry , vol.158 , Issue.3 , pp. 360-369
    • Kapur, S.1    Seeman, P.2
  • 15
    • 0034025771 scopus 로고    scopus 로고
    • 2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia
    • DOI 10.1176/appi.ajp.157.4.514
    • Kapur S, Zipursky R, Jones C, Remington G, Houle S. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 2000; 157: 514-520. (Pubitemid 30191189)
    • (2000) American Journal of Psychiatry , vol.157 , Issue.4 , pp. 514-520
    • Kapur, S.1    Zipursky, R.2    Jones, C.3    Remington, G.4    Houle, S.5
  • 18
    • 84857373066 scopus 로고    scopus 로고
    • Human Cytochrome P450 (CYP) Allele Nomenclature Committee accessed date: 22 June 2010
    • Human Cytochrome P450 (CYP) Allele Nomenclature Committee. http://www.cypalleles.ki.se/; accessed date: 22 June 2010.
  • 19
    • 0038103561 scopus 로고    scopus 로고
    • Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia
    • DOI 10.1097/00007691-200306000-00006
    • Mihara K, Kondo T, Yasui-Furukori N, Suzuki A, Ishida M, Ono S et al. Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia. Ther Drug Monit 2003; 25: 287-293. (Pubitemid 36638171)
    • (2003) Therapeutic Drug Monitoring , vol.25 , Issue.3 , pp. 287-293
    • Mihara, K.1    Kondo, T.2    Yasui-Furukori, N.3    Suzuki, A.4    Ishida, M.5    Ono, S.6    Kubota, T.7    Iga, T.8    Takarada, Y.9    De Vries, R.10    Kaneko, S.11
  • 21
    • 3242785620 scopus 로고    scopus 로고
    • Importance of P-glycoprotein at blood-tissue barriers
    • DOI 10.1016/j.tips.2004.06.002, PII S0165614704001713
    • Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 2004; 25: 423-429. (Pubitemid 38981558)
    • (2004) Trends in Pharmacological Sciences , vol.25 , Issue.8 , pp. 423-429
    • Fromm, M.F.1
  • 22
    • 50449094308 scopus 로고    scopus 로고
    • The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients
    • Kuzman MR, Medved V, Bozina N, Hotujac L, Sain I, Bilusic H. The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients. Psychiatry Res 2008; 160: 308-315.
    • (2008) Psychiatry Res , vol.160 , pp. 308-315
    • Kuzman, M.R.1    Medved, V.2    Bozina, N.3    Hotujac, L.4    Sain, I.5    Bilusic, H.6
  • 23
    • 33749850384 scopus 로고    scopus 로고
    • The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia
    • DOI 10.1097/01.ftd.0000246761.82377.a6, PII 0000769120061000000016
    • Lin Y-C, Ellingrod VL, Bishop JR, Miller DD. The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia. Ther Drug Monit 2006; 28: 668-672. (Pubitemid 44564067)
    • (2006) Therapeutic Drug Monitoring , vol.28 , Issue.5 , pp. 668-672
    • Lin, Y.-C.1    Ellingrod, V.L.2    Bishop, J.R.3    Miller, D.D.4
  • 24
    • 57649139354 scopus 로고    scopus 로고
    • Pharmacogenomics: The promise of personalized medicine for CNS disorders
    • de Leon J. Pharmacogenomics: the promise of personalized medicine for CNS disorders. Neuropsychopharmacology 2009; 34: 159-172.
    • (2009) Neuropsychopharmacology , vol.34 , pp. 159-172
    • De Leon, J.1
  • 25
    • 43049122356 scopus 로고    scopus 로고
    • From human genetics and genomics to pharmacogenetics and pharmacogenomics: Past lessons, future directions
    • DOI 10.1080/03602530801952864, PII 792810082
    • Nebert DW, Zhang G, Vesell ES. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev 2008; 40: 187-224. (Pubitemid 352000946)
    • (2008) Drug Metabolism Reviews , vol.40 , Issue.2 , pp. 187-224
    • Nebert, D.W.1    Zhang, G.2    Vesell, E.S.3
  • 26
    • 69449092098 scopus 로고    scopus 로고
    • Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications
    • Gentile S. Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications. Obes Rev 2009; 10: 527-542.
    • (2009) Obes Rev , vol.10 , pp. 527-542
    • Gentile, S.1
  • 27
    • 56049107653 scopus 로고    scopus 로고
    • Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study
    • Grossman I, Sullivan PF, Walley N, Liu Y, Dawson JR, Gumbs C et al. Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study. Genet Med 2008; 10: 720-729.
    • (2008) Genet Med , vol.10 , pp. 720-729
    • Grossman, I.1    Sullivan, P.F.2    Walley, N.3    Liu, Y.4    Dawson, J.R.5    Gumbs, C.6
  • 28
    • 67349227175 scopus 로고    scopus 로고
    • Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers
    • Ghotbi R, Gomez A, Milani L, Tybring G, Syvanen AC, Bertilsson L et al. Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers. Pharmacogenomics J 2009; 9: 208-217.
    • (2009) Pharmacogenomics J , vol.9 , pp. 208-217
    • Ghotbi, R.1    Gomez, A.2    Milani, L.3    Tybring, G.4    Syvanen, A.C.5    Bertilsson, L.6
  • 31
    • 62649152001 scopus 로고    scopus 로고
    • Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine
    • Gunes A, Melkersson KI, Scordo MG, Dahl M-L. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine. J Clin Psychopharmacol 2009; 29: 65-68.
    • (2009) J Clin Psychopharmacol , vol.29 , pp. 65-68
    • Gunes, A.1    Melkersson, K.I.2    Scordo, M.G.3    Dahl, M.-L.4
  • 32
    • 34748854911 scopus 로고    scopus 로고
    • The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: A cross-sectional study
    • DOI 10.1038/sj.tpj.6500422, PII 6500422
    • Mulder H, Franke B, van der-Beek van der AA, Arends J, Wilmink FW, Egberts ACG et al. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. Pharmacogenomics J 2007; 7: 318-324. (Pubitemid 47471309)
    • (2007) Pharmacogenomics Journal , vol.7 , Issue.5 , pp. 318-324
    • Mulder, H.1    Franke, B.2    Aart Van Der-Beek Van Der, A.3    Arends, J.4    Wilmink, F.W.5    Egberts, A.C.G.6    Scheffer, H.7
  • 34
    • 77952924290 scopus 로고    scopus 로고
    • Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample
    • Opgen-Rhein C, Brandl EJ, Muller DJ, Neuhaus AH, Tiwari AK, Sander T et al. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic- induced weight gain in a German sample. Pharmacogenomics 2010; 11: 773-780.
    • (2010) Pharmacogenomics , vol.11 , pp. 773-780
    • Opgen-Rhein, C.1    Brandl, E.J.2    Muller, D.J.3    Neuhaus, A.H.4    Tiwari, A.K.5    Sander, T.6
  • 35
    • 38349035863 scopus 로고    scopus 로고
    • Lack of association between the-759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients
    • Park Y-M, Cho J-H, Kang S-G, Choi J-E, Lee S-H, Kim L et al. Lack of association between the-759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients. J Clin Pharm Ther 2008; 33: 55-60.
    • (2008) J Clin Pharm Ther , vol.33 , pp. 55-60
    • Park, Y.-M.1    Cho, J.-H.2    Kang, S.-G.3    Choi, J.-E.4    Lee, S.-H.5    Kim, L.6
  • 36
    • 59149084186 scopus 로고    scopus 로고
    • DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain
    • Popp J, Leucht S, Heres S, Steimer W. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain. Pharmacogenomics J 2009; 9: 71-77.
    • (2009) Pharmacogenomics J , vol.9 , pp. 71-77
    • Popp, J.1    Leucht, S.2    Heres, S.3    Steimer, W.4
  • 38
    • 52649105994 scopus 로고    scopus 로고
    • Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: A cohort study
    • Ujike H, Nomura A, Morita Y, Morio A, Okahisa Y, Kotaka T et al. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study. J Clin Psychiatry 2008; 69: 1416-1422.
    • (2008) J Clin Psychiatry , vol.69 , pp. 1416-1422
    • Ujike, H.1    Nomura, A.2    Morita, Y.3    Morio, A.4    Okahisa, Y.5    Kotaka, T.6
  • 39
    • 44949234587 scopus 로고    scopus 로고
    • 2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia
    • DOI 10.1192/bjp.bp.107.041723
    • Yevtushenko OO, Cooper SJ, O'Neill R, Doherty JK, Woodside JV, Reynolds GP. Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. Br J Psychiatry 2008; 192: 424-428. (Pubitemid 351809894)
    • (2008) British Journal of Psychiatry , vol.192 , Issue.6 , pp. 424-428
    • Yevtushenko, O.O.1    Cooper, S.J.2    O'Neill, R.3    Doherty, J.K.4    Woodside, J.V.5    Reynolds, G.P.6
  • 40
    • 0032213142 scopus 로고    scopus 로고
    • Hypothalamic serotonin in control of eating behavior, meal size, and body weight
    • DOI 10.1016/S0006-3223(98)00186-3, PII S0006322398001863
    • Leibowitz SF, Alexander JT. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 1998; 44: 851-864. (Pubitemid 28520223)
    • (1998) Biological Psychiatry , vol.44 , Issue.9 , pp. 851-864
    • Leibowitz, S.F.1    Alexander, J.T.2
  • 42
    • 0034103054 scopus 로고    scopus 로고
    • Identification of polymorphic loci in the promoter region of the serotonin 5-HT(2c) receptor gene and their association with obesity and Type II diabetes
    • Yuan X, Yamada K, Ishiyama-Shigemoto S, Koyama W, Nonaka K. Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia 2000; 43: 373-376. (Pubitemid 30163481)
    • (2000) Diabetologia , vol.43 , Issue.3 , pp. 373-376
    • Yuan, X.1    Yamada, K.2    Ishiyama-Shigemoto, S.3    Koyama, W.4    Nonaka, K.5
  • 44
    • 34247547428 scopus 로고    scopus 로고
    • 2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity
    • DOI 10.1016/j.brainres.2007.02.038, PII S0006899307004350
    • Hill MJ, Reynolds GP. 5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity. Brain Res 2007; 1149: 14-17. (Pubitemid 46661934)
    • (2007) Brain Research , vol.1149 , Issue.1 , pp. 14-17
    • Hill, M.J.1    Reynolds, G.P.2
  • 45
    • 27544446224 scopus 로고    scopus 로고
    • The International HapMap Project Web site
    • DOI 10.1101/gr.4413105
    • Thorisson GA, Smith AV, Krishnan L, Stein LD. The international HapMap project web site. Genome Res 2005; 15: 1592-1593. (Pubitemid 41545013)
    • (2005) Genome Research , vol.15 , Issue.11 , pp. 1592-1593
    • Thorisson, G.A.1    Smith, A.V.2    Krishnan, L.3    Stein, L.D.4
  • 46
    • 67649446993 scopus 로고    scopus 로고
    • Focus on HTR2C: A possible suggestion for genetic studies of complex disorders
    • Drago A, Serretti A. Focus on HTR2C: a possible suggestion for genetic studies of complex disorders. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 601-637.
    • (2009) Am J Med Genet B Neuropsychiatr Genet , vol.150 B , pp. 601-637
    • Drago, A.1    Serretti, A.2
  • 48
    • 75549088045 scopus 로고    scopus 로고
    • Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
    • Laika B, Leucht S, Heres S, Schneider H, Steimer W. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. Pharmacogenomics J 2010; 10: 20-29.
    • (2010) Pharmacogenomics J , vol.10 , pp. 20-29
    • Laika, B.1    Leucht, S.2    Heres, S.3    Schneider, H.4    Steimer, W.5
  • 49
    • 79959436585 scopus 로고    scopus 로고
    • Polymorphisms of the LEP-, LEPR and HTR2C gene: Obesity and BMI change in patients using antipsychotic medication in a naturalistic setting
    • e-pub ahead of print 23 April 2011
    • Gregoor JG, van derWeide J, Loovers HM, van Megen HJ, Egberts TC, Heerdink ER. Polymorphisms of the LEP-, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting. Pharmacogenomics 2011; e-pub ahead of print 23 April 2011.
    • (2011) Pharmacogenomics
    • Gregoor, J.G.1    Van Derweide, J.2    Loovers, H.M.3    Van Megen, H.J.4    Egberts, T.C.5    Heerdink, E.R.6
  • 52
    • 67650486034 scopus 로고    scopus 로고
    • Serotonin receptor 2C and mental disorders: Genetic, expression and RNA editing studies
    • Iwamoto K, Bundo M, Kato T. Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies. RNA Biol 2009; 6: 248-253.
    • (2009) RNA Biol , vol.6 , pp. 248-253
    • Iwamoto, K.1    Bundo, M.2    Kato, T.3
  • 53
    • 23144441853 scopus 로고    scopus 로고
    • The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment
    • DOI 10.1016/j.pnpbp.2005.03.019, PII S0278584605001466
    • Reynolds GP, Templeman LA, Zhang ZJ. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1021-1028. (Pubitemid 41080129)
    • (2005) Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.29 , Issue.6 , pp. 1021-1028
    • Reynolds, G.P.1    Templeman, L.A.2    Zhang, Z.J.3
  • 54
    • 78649711976 scopus 로고    scopus 로고
    • Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: An update and meta-analysis
    • Sicard MN, Zai CC, Tiwari AK, Souza RP, Meltzer HY, Lieberman JA et al. Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis. Pharmacogenomics 2010; 11: 1561-1571.
    • (2010) Pharmacogenomics , vol.11 , pp. 1561-1571
    • Sicard, M.N.1    Zai, C.C.2    Tiwari, A.K.3    Souza, R.P.4    Meltzer, H.Y.5    Lieberman, J.A.6
  • 55
    • 0027520871 scopus 로고
    • Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients
    • DOI 10.1016/0006-3223(93)90288-O
    • Nordstrom AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C et al. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 1993; 33: 227-235. (Pubitemid 23091497)
    • (1993) Biological Psychiatry , vol.33 , Issue.4 , pp. 227-235
    • Nordstrom, A.-L.1    Farde, L.2    Wiesel, F.-A.3    Forslund, K.4    Pauli, S.5    Halldin, C.6    Uppfeldt, G.7
  • 57
    • 77952424738 scopus 로고    scopus 로고
    • Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment
    • Hong C-J, Liou Y-J, Bai YM, Chen T-T, Wang Y-C, Tsai S-J. Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment. Pharmacogenetics Genomics 2010; 20: 359-366.
    • (2010) Pharmacogenetics Genomics , vol.20 , pp. 359-366
    • Hong, C.-J.1    Liou, Y.-J.2    Bai, Y.M.3    Chen, T.-T.4    Wang, Y.-C.5    Tsai, S.-J.6
  • 58
    • 13444301359 scopus 로고    scopus 로고
    • Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients
    • DOI 10.1016/j.neulet.2004.11.014
    • Wu S, Xing Q, Gao R, Li X, Gu N, Feng G et al. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients. Neurosci Lett 2005; 376: 1-4. (Pubitemid 40202926)
    • (2005) Neuroscience Letters , vol.376 , Issue.1 , pp. 1-4
    • Wu, S.1    Xing, Q.2    Gao, R.3    Li, X.4    Gu, N.5    Feng, G.6    He, L.7
  • 59
    • 0036161787 scopus 로고    scopus 로고
    • The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms
    • DOI 10.1046/j.1440-1819.2002.00935.x
    • Himei A, Koh J, Sakai J, Inada Y, Akabame K, Yoneda H. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and-141C Ins/Del polymorphisms. Psychiatry Clin Neurosci 2002; 56: 97-102. (Pubitemid 34130626)
    • (2002) Psychiatry and Clinical Neurosciences , vol.56 , Issue.1 , pp. 97-102
    • Himei, A.1    Koh, J.2    Sakai, J.3    Inada, Y.4    Akabame, K.5    Yoneda, H.6
  • 60
    • 0030933979 scopus 로고    scopus 로고
    • A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
    • DOI 10.1093/hmg/6.4.577
    • Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997; 6: 577-582. (Pubitemid 27142107)
    • (1997) Human Molecular Genetics , vol.6 , Issue.4 , pp. 577-582
    • Arinami, T.1    Gao, M.2    Hamaguchi, H.3    Toru, M.4
  • 61
    • 0033009871 scopus 로고    scopus 로고
    • Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
    • Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999; 4: 290-296. (Pubitemid 29292183)
    • (1999) Molecular Psychiatry , vol.4 , Issue.3 , pp. 290-296
    • Jonsson, E.G.1    Nothen, M.M.2    Grunhage, F.3    Farde, L.4    Nakashima, Y.5    Propping, P.6    Sedvall, G.C.7
  • 62
    • 77955919157 scopus 로고    scopus 로고
    • DRD2 promoter region variation predicts antipsychoticinduced weight gain in first episode schizophrenia
    • Lencz T, Robinson DG, Napolitano B, Sevy S, Kane JM, Goldman D et al. DRD2 promoter region variation predicts antipsychoticinduced weight gain in first episode schizophrenia. Pharmacogenet Genomics 2010; 20: 569-572.
    • (2010) Pharmacogenet Genomics , vol.20 , pp. 569-572
    • Lencz, T.1    Robinson, D.G.2    Napolitano, B.3    Sevy, S.4    Kane, J.M.5    Goldman, D.6
  • 63
    • 84859007723 scopus 로고    scopus 로고
    • Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain
    • e-pub ahead of print 17 August 2010
    • Müller DJ, Zai CC, Sicard M, Remington E, Souza RP, Tiwari AK et al. Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain. Pharmacogenomics J 2010; e-pub ahead of print 17 August 2010.
    • (2010) Pharmacogenomics J
    • Müller, D.J.1    Zai, C.C.2    Sicard, M.3    Remington, E.4    Souza, R.P.5    Tiwari, A.K.6
  • 64
    • 0030229897 scopus 로고    scopus 로고
    • 2 receptor (DRD2) gene
    • Comings DE, Gade R, MacMurray JP, Muhleman D, Peters WR. Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol Psychiatry 1996; 1: 325-335. (Pubitemid 126441317)
    • (1996) Molecular Psychiatry , vol.1 , Issue.4 , pp. 325-335
    • Comings, D.E.1    Gade, R.2    MacMurray, J.P.3    Muhleman, D.4    Peters, W.R.5
  • 66
    • 0037320652 scopus 로고    scopus 로고
    • Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
    • DOI 10.1093/hmg/ddg055
    • Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Human Mol Genet 2003; 12: 205-216. (Pubitemid 36204418)
    • (2003) Human Molecular Genetics , vol.12 , Issue.3 , pp. 205-216
    • Duan, J.1    Wainwright, M.S.2    Comeron, J.M.3    Saitou, N.4    Sanders, A.R.5    Gelernter, J.6    Gejman, P.V.7
  • 67
    • 70349102541 scopus 로고    scopus 로고
    • C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity
    • Hirvonen MM, Laakso A, Na°gren K, Rinne JO, Pohjalainen T, Hietala J. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 2009; 63: 907-912.
    • (2009) Synapse , vol.63 , pp. 907-912
    • Hirvonen, M.M.1    Laakso, A.2    Nagren, K.3    Rinne, J.O.4    Pohjalainen, T.5    Hietala, J.6
  • 69
    • 0027485692 scopus 로고
    • Dopamine D4 receptors elevated in schizophrenia
    • DOI 10.1038/365441a0
    • Seeman P, Guan HC, Van Tol HH. Dopamine D4 receptors elevated in schizophrenia. Nature 1993; 365: 441-445. (Pubitemid 23311038)
    • (1993) Nature , vol.365 , Issue.6445 , pp. 441-445
    • Seeman, P.1    Guan, H.-C.2    Van Tol, H.H.M.3
  • 72
    • 77953611280 scopus 로고    scopus 로고
    • A season-of-birth/DRD4 interaction predicts maximal body mass index in women with bulimia nervosa
    • Levitan RD, Kaplan AS, Davis C, Lam RW, Kennedy JL. A season-of-birth/DRD4 interaction predicts maximal body mass index in women with bulimia nervosa. Neuropsychopharmacology 2010; 35: 1729-1733.
    • (2010) Neuropsychopharmacology , vol.35 , pp. 1729-1733
    • Levitan, R.D.1    Kaplan, A.S.2    Davis, C.3    Lam, R.W.4    Kennedy, J.L.5
  • 73
    • 33750201905 scopus 로고    scopus 로고
    • A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype Hypothesis
    • DOI 10.1038/sj.npp.1301121, PII 1301121
    • Levitan RD, Masellis M, Lam RW, Kaplan AS, Davis C, Tharmalingam S et al. A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: a seasonal thrifty phenotype hypothesis. Neuropsychopharmacology 2006; 31: 2498-2503. (Pubitemid 44607067)
    • (2006) Neuropsychopharmacology , vol.31 , Issue.11 , pp. 2498-2503
    • Levitan, R.D.1    Masellis, M.2    Lam, R.W.3    Kaplan, A.S.4    Davis, C.5    Tharmalingam, S.6    Mackenzie, B.7    Basile, V.S.8    Kennedy, J.L.9
  • 75
    • 0347363538 scopus 로고    scopus 로고
    • Role of Dopamine D3 Receptor (DRD3) and Dopamine Transporter (DAT) Polymorphism in Cognitive Dysfunctions and Therapeutic Response to Atypical Antipsychotics in Patients with Schizophrenia
    • Szekeres G, Keri S, Juhasz A, Rimanoczy A, Szendi I, Czimmer C et al. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004; 124B: 1-5. (Pubitemid 38031583)
    • (2004) American Journal of Medical Genetics - Neuropsychiatric Genetics , vol.124 B , Issue.1 , pp. 1-5
    • Szekeres, G.1    Keri, S.2    Juhasz, A.3    Rimanoczy, A.4    Szendi, I.5    Czimmer, C.6    Janka, Z.7
  • 76
    • 34548688721 scopus 로고    scopus 로고
    • Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder
    • DOI 10.1038/sj.npp.1301348, PII 1301348
    • Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C et al. Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology 2007; 32: 2199-2206. (Pubitemid 47417697)
    • (2007) Neuropsychopharmacology , vol.32 , Issue.10 , pp. 2199-2206
    • Davis, C.1    Levitan, R.D.2    Kaplan, A.S.3    Carter, J.4    Reid, C.5    Curtis, C.6    Patte, K.7    Kennedy, J.L.8
  • 77
    • 29244462877 scopus 로고    scopus 로고
    • Cognitive neuroscience of emotional memory
    • DOI 10.1038/nrn1825
    • LaBar KS, Cabeza R. Cognitive neuroscience of emotional memory. Nat Rev Neurosci 2006; 7: 54-64. (Pubitemid 41828931)
    • (2006) Nature Reviews Neuroscience , vol.7 , Issue.1 , pp. 54-64
    • LaBar, K.S.1    Cabeza, R.2
  • 80
    • 75549092068 scopus 로고    scopus 로고
    • ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics
    • Liu YR, Loh EW, Lan TH, Chen SF, Yu YH, Chang YH et al. ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics. Pharmacogenomics J 2010; 10: 30-39.
    • (2010) Pharmacogenomics J , vol.10 , pp. 30-39
    • Liu, Y.R.1    Loh, E.W.2    Lan, T.H.3    Chen, S.F.4    Yu, Y.H.5    Chang, Y.H.6
  • 81
    • 70449510603 scopus 로고    scopus 로고
    • Association of the alpha 2A adrenergic receptor-1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans
    • Sickert L, Müller DJ, Tiwari AK, Shaikh S, Zai C, De Souza R et al. Association of the alpha 2A adrenergic receptor-1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans. Pharmacogenomics 2009; 10: 1169-1176.
    • (2009) Pharmacogenomics , vol.10 , pp. 1169-1176
    • Sickert, L.1    Müller, D.J.2    Tiwari, A.K.3    Shaikh, S.4    Zai, C.5    De Souza, R.6
  • 82
    • 0032577309 scopus 로고    scopus 로고
    • The search for human obesity genes
    • DOI 10.1126/science.280.5368.1374
    • Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998; 280: 1374-1377. (Pubitemid 28264818)
    • (1998) Science , vol.280 , Issue.5368 , pp. 1374-1377
    • Comuzzie, A.G.1    Allison, D.B.2
  • 85
    • 77952889345 scopus 로고    scopus 로고
    • Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents
    • Kim SH, Nikolics L, Abbasi F, Lamendola C, Link J, Reaven GM et al. Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents. J Psychiatr Res 2010; 44: 493-498.
    • (2010) J Psychiatr Res , vol.44 , pp. 493-498
    • Kim, S.H.1    Nikolics, L.2    Abbasi, F.3    Lamendola, C.4    Link, J.5    Reaven, G.M.6
  • 86
    • 78951469329 scopus 로고    scopus 로고
    • Association study of energy homeostasis genes and antipsychotic-induced weight gain in patients with schizophrenia
    • Jassim G, Ferno J, Theisen FM, Haberhausen M, Christoforou A, Havik B et al. Association study of energy homeostasis genes and antipsychotic-induced weight gain in patients with schizophrenia. Pharmacopsychiatry 2011; 44: 15-20.
    • (2011) Pharmacopsychiatry , vol.44 , pp. 15-20
    • Jassim, G.1    Ferno, J.2    Theisen, F.M.3    Haberhausen, M.4    Christoforou, A.5    Havik, B.6
  • 88
    • 0037675120 scopus 로고    scopus 로고
    • G-protien β3 subunit 825T allele and hypertension
    • Siffert W. G-protein beta3 subunit 825T allele and hypertension. Curr Hypertens Rep 2003; 5: 47-53. (Pubitemid 38898932)
    • (2003) Current Hypertension Reports , vol.5 , Issue.1 , pp. 47-53
    • Siffert, W.1
  • 89
    • 0035113135 scopus 로고    scopus 로고
    • Association between a polymorphism in the G protein β3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction
    • DOI 10.1016/S0008-6363(00)00292-3, PII S0008636300002923
    • Hengstenberg C, Schunkert H, Mayer B, Döring A, Löwel H, Hense HW et al. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001; 49: 820-827. (Pubitemid 32178386)
    • (2001) Cardiovascular Research , vol.49 , Issue.4 , pp. 820-827
    • Hengstenberg, C.1    Schunkert, H.2    Mayer, B.3    Doring, A.4    Lowel, H.5    Hense, H.-W.6    Fischer, M.7    Riegger, G.A.J.8    Holmer, S.R.9
  • 90
    • 0033405439 scopus 로고    scopus 로고
    • Association between the C825T polymorphism of the G protein β3-subunit gene and hypertension in blacks
    • Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP. Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks. Hypertension 1999; 34: 1193-1196. (Pubitemid 30002381)
    • (1999) Hypertension , vol.34 , Issue.6 , pp. 1193-1196
    • Dong, Y.1    Zhu, H.2    Sagnella, G.A.3    Carter, N.D.4    Cook, D.G.5    Cappuccio, F.P.6
  • 92
    • 0032589474 scopus 로고    scopus 로고
    • G-protein β3 subunit gene splice variant and body fat distribution in nunavut Inuit
    • DOI 10.1101/gr.9.10.972
    • Hegele RA, Anderson C, Young TK, Connelly PW. G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res 1999; 9: 972-977. (Pubitemid 29525205)
    • (1999) Genome Research , vol.9 , Issue.10 , pp. 972-977
    • Hegele, R.A.1    Anderson, C.2    Young, T.K.3    Connelly, P.W.4
  • 94
    • 0036020753 scopus 로고    scopus 로고
    • 3 polymorphism on adrenoceptor-mediated lipolysis in human fat cells
    • Rydén M, Faulds G, Hoffstedt J, Wennlund A, Arner P. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 2002; 51: 1601-1608. (Pubitemid 34826631)
    • (2002) Diabetes , vol.51 , Issue.5 , pp. 1601-1608
    • Ryden, M.1    Faulds, G.2    Hoffstedt, J.3    Wennlund, A.4    Arner, P.5
  • 95
    • 0041881989 scopus 로고    scopus 로고
    • Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein β3 subunit gene (GNB3) C825T polymorphism
    • DOI 10.1097/00008571-200308000-00003
    • Hauner H, Meier M, Jöckel K-H, Frey UH, Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 2003; 13: 453-459. (Pubitemid 37034587)
    • (2003) Pharmacogenetics , vol.13 , Issue.8 , pp. 453-459
    • Hauner, H.1    Meier, M.2    Jockel, K.-H.3    Frey, U.H.4    Siffert, W.5
  • 96
    • 70249136845 scopus 로고    scopus 로고
    • Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene
    • Hsiao D-J, Wu LS-H, Huang S-Y, Lin E. Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene. Pharmacogenetics Genomics 2009; 19: 730-733.
    • (2009) Pharmacogenetics Genomics , vol.19 , pp. 730-733
    • Hsiao, D.-J.1    Ls-H, W.2    Huang, S.-Y.3    Lin, E.4
  • 97
    • 32044467124 scopus 로고    scopus 로고
    • Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to Olanzapine or Olanzapine-related weight gain persons with schizophrenia
    • Bishop JR, Ellingrod VL, Moline J, Miller D. Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia. Med Sci Monit 2006; 12: BR47-BR50. (Pubitemid 43200936)
    • (2006) Medical Science Monitor , vol.12 , Issue.2
    • Bishop, J.R.1    Ellingrod, V.L.2    Moline, J.3    Miller, D.4
  • 98
    • 64249151960 scopus 로고    scopus 로고
    • G-protein beta3 subunit gene 825C/T polymorphism is not associated with olanzapine-induced weight gain in Korean schizophrenic patients
    • Park Y-M, Chung Y-C, Lee S-H, Lee K-J, Kim H, Choi J-E et al. G-protein beta3 subunit gene 825C/T polymorphism is not associated with olanzapine-induced weight gain in Korean schizophrenic patients. Psychiatry Invest 2009; 6: 39-43.
    • (2009) Psychiatry Invest , vol.6 , pp. 39-43
    • Park, Y.-M.1    Chung, Y.-C.2    Lee, S.-H.3    Lee, K.-J.4    Kim, H.5    Choi, J.-E.6
  • 99
    • 2942556680 scopus 로고    scopus 로고
    • The synaptic vesicle cycle
    • DOI 10.1146/annurev.neuro.26.041002.131412
    • Sudhof TC. The synaptic vesicle cycle. Ann Rev Neurosci 2004; 27: 509-547. (Pubitemid 39050412)
    • (2004) Annual Review of Neuroscience , vol.27 , pp. 509-547
    • Sudhof, T.C.1
  • 100
    • 0033513495 scopus 로고    scopus 로고
    • Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic β-cells is involved in impaired insulin secretion from diabetic GK rat islets: Restoration of decreased t-SNARE proteins improves impaired insulin secretion
    • Nagamatsu S, Nakamichi Y, Yamamura C, Matsushima S, Watanabe T, Ozawa S et al. Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes 1999; 48: 2367-2373. (Pubitemid 30395428)
    • (1999) Diabetes , vol.48 , Issue.12 , pp. 2367-2373
    • Nagamatsu, S.1    Nakamichi, Y.2    Yamamura, C.3    Matsushima, S.4    Watanabe, T.5    Ozawa, S.6    Furukawa, H.7    Ishida, H.8
  • 101
    • 0028940786 scopus 로고
    • SNAP-25 is expressed in islets of Langerhans and is involved in insulin release
    • Sadoul K, Lang J, Montecucco C, Weller U, Regazzi R, Catsicas S et al. SNAP-25 is expressed in islets of Langerhans and is involved in insulin release. J Cell Biol 1995; 128: 1019-1028.
    • (1995) J Cell Biol , vol.128 , pp. 1019-1028
    • Sadoul, K.1    Lang, J.2    Montecucco, C.3    Weller, U.4    Regazzi, R.5    Catsicas, S.6
  • 103
    • 20144388485 scopus 로고    scopus 로고
    • The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia
    • Müller DJ, Klempan TA, De Luca V, Sicard T, Volavka J, Czobor P et al. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Neurosci Lett 2005; 379: 81-89.
    • (2005) Neurosci Lett , vol.379 , pp. 81-89
    • Müller, D.J.1    Klempan, T.A.2    De Luca, V.3    Sicard, T.4    Volavka, J.5    Czobor, P.6
  • 105
    • 0002007231 scopus 로고    scopus 로고
    • Metabolic abnormalities and the role of leptin in human obesity
    • Pi-Sunyer FX, Laferrere B. Metabolic abnormalities and the role of leptin in human obesity. J Clin Endocrinol Metab 1999; 84: 3-7.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 3-7
    • Pi-Sunyer, F.X.1    Laferrere, B.2
  • 106
    • 54249162906 scopus 로고    scopus 로고
    • Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: A review
    • Sentissi O, Epelbaum J, Olié J-P, Poirier M-F. Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review. Schizophr Bull 2008; 34: 1189-1199.
    • (2008) Schizophr Bull , vol.34 , pp. 1189-1199
    • Sentissi, O.1    Epelbaum, J.2    Olié, J.-P.3    Poirier, M.-F.4
  • 107
    • 67650070739 scopus 로고    scopus 로고
    • Functional analysis of the-2548G/A leptin gene polymorphism in breast cancer cells
    • Terrasi M, Fiorio E, Mercanti A, Koda M, Moncada CA, Sulkowski S et al. Functional analysis of the-2548G/A leptin gene polymorphism in breast cancer cells. Int J Cancer 2009; 125: 1038-1044.
    • (2009) Int J Cancer , vol.125 , pp. 1038-1044
    • Terrasi, M.1    Fiorio, E.2    Mercanti, A.3    Koda, M.4    Moncada, C.A.5    Sulkowski, S.6
  • 108
    • 0036628931 scopus 로고    scopus 로고
    • A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin
    • Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002; 34: 355-359.
    • (2002) Horm Metab Res , vol.34 , pp. 355-359
    • Hoffstedt, J.1    Eriksson, P.2    Mottagui-Tabar, S.3    Arner, P.4
  • 110
    • 34248592726 scopus 로고    scopus 로고
    • Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population
    • DOI 10.1097/jcp.0b013e3180582412, PII 0000471420070600000002
    • Zhang XY, Tan YL, Zhou DF, Haile CN, Cao LY, Xu Q et al. Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population. J Clin Psychopharmacol 2007; 27: 246-251. (Pubitemid 46763305)
    • (2007) Journal of Clinical Psychopharmacology , vol.27 , Issue.3 , pp. 246-251
    • Zhang, X.Y.1    Tan, Y.L.2    Zhou, D.F.3    Haile, C.N.4    Cao, L.Y.5    Xu, Q.6    Shen, Y.7    Kosten, T.A.8    Kosten, T.R.9
  • 111
    • 44449098227 scopus 로고    scopus 로고
    • 2548G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: A study of nuclear family-based association]
    • Mou X-D, Zhang Z-J, Zhang X-R, Shi J-B, Sun J. 2548G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008; 33: 316-320.
    • (2008) Zhong Nan da Xue Xue Bao Yi Xue Ban , vol.33 , pp. 316-320
    • Mou, X.-D.1    Zhang, Z.-J.2    Zhang, X.-R.3    Shi, J.-B.4    Sun, J.5
  • 114
    • 34247890009 scopus 로고    scopus 로고
    • Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia
    • Ellingrod VL, Bishop JR, Moline J, Lin Y-C, Miller DD. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. Psychopharmacol Bull 2007; 40: 57-62.
    • (2007) Psychopharmacol Bull , vol.40 , pp. 57-62
    • Ellingrod, V.L.1    Bishop, J.R.2    Moline, J.3    Lin, Y.-C.4    Miller, D.D.5
  • 116
    • 0037456774 scopus 로고    scopus 로고
    • Defective melanocortin 4 receptors in hyperphagia and morbid obesity
    • DOI 10.1056/NEJMe030013
    • List JF, Habener JF. Defective melanocortin 4 receptors in hyperphagia and morbid obesity. N Engl J Med 2003; 348: 1160-1163. (Pubitemid 36337327)
    • (2003) New England Journal of Medicine , vol.348 , Issue.12 , pp. 1160-1163
    • List, J.F.1    Habener, J.F.2
  • 117
    • 14544272858 scopus 로고    scopus 로고
    • Monogenic obesity in humans
    • DOI 10.1146/annurev.med.56.062904.144924
    • Farooqi IS, O'Rahilly S. Monogenic obesity in humans. Annu Rev Med 2005; 56: 443-458. (Pubitemid 40299792)
    • (2005) Annual Review of Medicine , vol.56 , pp. 443-458
    • Farooqi, I.S.1    O'Rahilly, S.2
  • 118
    • 0034905674 scopus 로고    scopus 로고
    • Mutational analysis of melanocortin-4 receptor, agouti-related protein, and α-melanocyte-stimulating hormone genes in severely obese children
    • DOI 10.1067/mpd.2001.116284
    • Dubern B, Clement K, Pelloux V, Froguel P, Girardet JP, Guy-Grand B et al. Mutational analysis of melanocortin-4 receptor, agoutirelated protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 2001; 139: 204-209. (Pubitemid 32721705)
    • (2001) Journal of Pediatrics , vol.139 , Issue.2 , pp. 204-209
    • Dubern, B.1    Clement, K.2    Pelloux, V.3    Froguel, P.4    Girardet, J.-P.5    Guy-Grand, B.6    Tounian, P.7
  • 121
    • 59149097625 scopus 로고    scopus 로고
    • Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations
    • Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, Gallina S et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009; 41: 157-159.
    • (2009) Nat Genet , vol.41 , pp. 157-159
    • Meyre, D.1    Delplanque, J.2    Chevre, J.C.3    Lecoeur, C.4    Lobbens, S.5    Gallina, S.6
  • 122
    • 0035656688 scopus 로고    scopus 로고
    • Non-coding RNA genes and the modern RNA world
    • DOI 10.1038/35103511
    • Eddy SR. Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2001; 2: 919-929. (Pubitemid 33691089)
    • (2001) Nature Reviews Genetics , vol.2 , Issue.12 , pp. 919-929
    • Eddy, S.R.1
  • 124
    • 0347510636 scopus 로고    scopus 로고
    • The neonatal ventral hippocampal lesion model of schizophrenia: Effects on dopamine and GABA mRNA markers in the rat midbrain
    • DOI 10.1111/j.1460-9568.2003.03047.x
    • Lipska BK, Lerman DN, Khaing ZZ, Weinberger DR. The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain. Eur J Neurosci 2003; 18: 3097-3104. (Pubitemid 38021551)
    • (2003) European Journal of Neuroscience , vol.18 , Issue.11 , pp. 3097-3104
    • Lipska, B.K.1    Lerman, D.N.2    Khaing, Z.Z.3    Weinberger, D.R.4
  • 126
    • 77249134520 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system
    • Cordeira JW, Frank L, Sena-Esteves M, Pothos EN, Rios M. Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system. J Neurosci 2010; 30: 2533-2541.
    • (2010) J Neurosci , vol.30 , pp. 2533-2541
    • Cordeira, J.W.1    Frank, L.2    Sena-Esteves, M.3    Pothos, E.N.4    Rios, M.5
  • 127
    • 80052059755 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor levels in schizophrenia: A systematic review with meta-analysis
    • e-pub ahead of print 24 August 2010
    • Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry 2010; e-pub ahead of print 24 August 2010.
    • (2010) Mol Psychiatry
    • Green, M.J.1    Matheson, S.L.2    Shepherd, A.3    Weickert, C.S.4    Carr, V.J.5
  • 128
    • 33947235663 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor Val66Met and psychiatric disorders: Meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia
    • DOI 10.1016/j.biopsych.2006.08.025, PII S0006322306010729
    • Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 2007; 61: 911-922. (Pubitemid 46420580)
    • (2007) Biological Psychiatry , vol.61 , Issue.7 , pp. 911-922
    • Gratacos, M.1    Gonzalez, J.R.2    Mercader, J.M.3    De Cid, R.4    Urretavizcaya, M.5    Estivill, X.6
  • 131
  • 132
    • 0034640334 scopus 로고    scopus 로고
    • 2 receptor antagonist, BIIE0246 on neuropeptide Y release
    • DOI 10.1016/S0014-2999(00)00230-2, PII S0014299900002302
    • King PJ, Williams G, Doods H, Widdowson PS. Effect of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246 on neuropeptide Y release. Eur J Pharmacol 2000; 396: R1-R3. (Pubitemid 30261560)
    • (2000) European Journal of Pharmacology , vol.396 , Issue.1
    • King, P.J.1    Williams, G.2    Doods, H.3    Widdowson, P.S.4
  • 135
    • 11244270333 scopus 로고    scopus 로고
    • A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses
    • DOI 10.1038/sj.mp.4001537
    • Chagnon YC, Mérette C, Bouchard RH, Emond C, Roy MA, Maziade M. A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses. Mol Psychiatry 2004; 9: 1067-1074. (Pubitemid 40065451)
    • (2004) Molecular Psychiatry , vol.9 , Issue.12 , pp. 1067-1074
    • Chagnon, Y.C.1    Merette, C.2    Bouchard, R.H.3    Emond, C.4    Roy, M.-A.5    Maziade, M.6
  • 137
    • 33845673559 scopus 로고    scopus 로고
    • Endocannabinoids and the control of energy balance
    • DOI 10.1016/j.tem.2006.11.006, PII S1043276006002438
    • Matias I, DiMarzo V. Endocannabinoids and the control of energy balance. Trends EndocrinolMetab 2007; 18: 27-37. (Pubitemid 44960014)
    • (2007) Trends in Endocrinology and Metabolism , vol.18 , Issue.1 , pp. 27-37
    • Matias, I.1    Di Marzo, V.2
  • 139
    • 77951098236 scopus 로고    scopus 로고
    • A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in schizophrenia
    • Tiwari AK, Zai CC, Likhodi O, Lisker A, Singh D, Souza RP et al. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in schizophrenia. Neuropsychopharmacology 2010; 35: 1315-1324.
    • (2010) Neuropsychopharmacology , vol.35 , pp. 1315-1324
    • Tiwari, A.K.1    Zai, C.C.2    Likhodi, O.3    Lisker, A.4    Singh, D.5    Souza, R.P.6
  • 140
    • 77955129795 scopus 로고    scopus 로고
    • Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain
    • Monteleone P, Milano W, Petrella C, Canestrelli B, Maj M. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain. J Clin Psychopharmacol 2010; 30: 441-445.
    • (2010) J Clin Psychopharmacol , vol.30 , pp. 441-445
    • Monteleone, P.1    Milano, W.2    Petrella, C.3    Canestrelli, B.4    Maj, M.5
  • 141
    • 33750980390 scopus 로고    scopus 로고
    • Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: Marked differences between various antipsychotic drugs
    • Fern J, Skrede S, Vik-Mo AO, Ha°vik B, Steen VM. Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs. BMC Neurosci 2006; 7: 69.
    • (2006) BMC Neurosci , vol.7 , pp. 69
    • Fern, J.1    Skrede, S.2    Vik-Mo, A.O.3    Havik, B.4    Steen, V.M.5
  • 142
    • 60549089825 scopus 로고    scopus 로고
    • Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotictreated schizophrenic patients: Perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    • Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Fernø J, Gebhardt S et al. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotictreated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Mol Psychiatry 2009; 14: 308-317.
    • (2009) Mol Psychiatry , vol.14 , pp. 308-317
    • Le Hellard, S.1    Theisen, F.M.2    Haberhausen, M.3    Raeder, M.B.4    Fernø, J.5    Gebhardt, S.6
  • 143
    • 77950902489 scopus 로고    scopus 로고
    • Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients
    • Tiwari AK, Zai CC, Meltzer HY, Lieberman JA, Müller DJ, Kennedy JL. Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients. Hum Psychopharmacol 2010; 25: 253-259.
    • (2010) Hum Psychopharmacol , vol.25 , pp. 253-259
    • Tiwari, A.K.1    Zai, C.C.2    Meltzer, H.Y.3    Lieberman, J.A.4    Müller, D.J.5    Kennedy, J.L.6
  • 144
    • 50149118604 scopus 로고    scopus 로고
    • Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: Role of metabolic pathway genes
    • Srivastava V, Deshpande SN, Nimgaonkar VL, Lerer B, Thelma B. Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes. Pharmacogenomics 2008; 9: 1055-1068.
    • (2008) Pharmacogenomics , vol.9 , pp. 1055-1068
    • Srivastava, V.1    Deshpande, S.N.2    Nimgaonkar, V.L.3    Lerer, B.4    Thelma, B.5
  • 145
    • 44049109281 scopus 로고    scopus 로고
    • Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia
    • DOI 10.1038/sj.tpj.6500474, PII 6500474
    • Smith RC, Segman RH, Golcer-Dubner T, Pavlov V, Lerer B. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia. Pharmacogenomics J 2008; 8: 228-236. (Pubitemid 351712647)
    • (2008) Pharmacogenomics Journal , vol.8 , Issue.3 , pp. 228-236
    • Smith, R.C.1    Segman, R.H.2    Golcer-Dubner, T.3    Pavlov, V.4    Lerer, B.5
  • 146
    • 0032790648 scopus 로고    scopus 로고
    • Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis
    • DOI 10.1016/S0022-3956(99)00021-7, PII S0022395699000217
    • Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kühn M, Schuld A et al. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 1999; 33: 407-418. (Pubitemid 29392689)
    • (1999) Journal of Psychiatric Research , vol.33 , Issue.5 , pp. 407-418
    • Haack, M.1    Hinze-Selch, D.2    Fenzel, T.3    Kraus, T.4    Kuhn, M.5    Schuld, A.6    Pollmacher, T.7
  • 147
    • 0029846298 scopus 로고    scopus 로고
    • Effects of clozapine on plasma cytokine and soluble cytokine receptor levels
    • DOI 10.1097/00004714-199610000-00011
    • Pollmächer T, Hinze-Selch D, Mullington J. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol 1996; 16: 403-409. (Pubitemid 26352672)
    • (1996) Journal of Clinical Psychopharmacology , vol.16 , Issue.5 , pp. 403-409
    • Pollmacher, T.1    Hinze-Selch, D.2    Mullington, J.3
  • 148
    • 33748557803 scopus 로고    scopus 로고
    • Family and case-control association study of the tumor necrosis factor-alpha (TNF-α) gene with schizophrenia and response to antipsychotic medication
    • DOI 10.1007/s00213-006-0482-4
    • Zai G, Müller DJ, Volavka J, Czobor P, Lieberman JA, Meltzer HY et al. Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication. Psychopharmacology 2006; 188: 171-182. (Pubitemid 44371155)
    • (2006) Psychopharmacology , vol.188 , Issue.2 , pp. 171-182
    • Zai, G.1    Muller, D.J.2    Volavka, J.3    Czobor, P.4    Lieberman, J.A.5    Meltzer, H.Y.6    Kennedy, J.L.7
  • 149
    • 77953937453 scopus 로고    scopus 로고
    • Genetic association between TNFa-308 G>A polymorphism and longitudinal weight change during clozapine treatment
    • Wang Y-C, Bai Y-M, Chen J-Y, Lin C-C, Lai I-C, Liou Y-J. Genetic association between TNFa-308 G>A polymorphism and longitudinal weight change during clozapine treatment. Hum Psychopharmacol 2010; 25: 303-309.
    • (2010) Hum Psychopharmacol , vol.25 , pp. 303-309
    • Wang, Y.-C.1    Bai, Y.-M.2    Chen, J.-Y.3    Lin, C.-C.4    Lai, I.-C.5    Liou, Y.-J.6
  • 150
    • 79951813616 scopus 로고    scopus 로고
    • Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
    • Adkins DE, Aberg K, McClay JL, Bukszar J, Zhao Z, Jia P et al. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. Mol Psychiatry 2010; 16: 321-332.
    • (2010) Mol Psychiatry , vol.16 , pp. 321-332
    • Adkins, D.E.1    Aberg, K.2    McClay, J.L.3    Bukszar, J.4    Zhao, Z.5    Jia, P.6
  • 151
    • 58149163142 scopus 로고    scopus 로고
    • Six new loci associated with body mass index highlight a neuronal influence on body weight regulation
    • Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41: 25-34.
    • (2009) Nat Genet , vol.41 , pp. 25-34
    • Willer, C.J.1    Speliotes, E.K.2    Loos, R.J.3    Li, S.4    Lindgren, C.M.5    Heid, I.M.6
  • 155
    • 0034910756 scopus 로고    scopus 로고
    • Bodyweight gain associated with atypical antipsychotics: Epidemiology and therapeutic implications
    • Russell JM, Mackell JA. Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications. CNS Drugs 2001; 15: 537-551. (Pubitemid 32735379)
    • (2001) CNS Drugs , vol.15 , Issue.7 , pp. 537-551
    • Russell, J.M.1    Mackell, J.A.2
  • 156
    • 0036607520 scopus 로고    scopus 로고
    • Changes in body mass index for individuals with and without schizophrenia, 1987-1996
    • DOI 10.1016/S0920-9964(01)00256-0, PII S0920996401002560
    • Homel P, Casey D, Allison DB. Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophr Res 2002; 55: 277-284. (Pubitemid 34607382)
    • (2002) Schizophrenia Research , vol.55 , Issue.3 , pp. 277-284
    • Homel, P.1    Casey, D.2    Allison, D.B.3
  • 157
    • 0348014397 scopus 로고    scopus 로고
    • Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study
    • DOI 10.1192/bjp.183.6.534
    • McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003; 183: 534-539. (Pubitemid 37533200)
    • (2003) British Journal of Psychiatry , vol.183 , Issue.DEC. , pp. 534-539
    • McCreadie, R.G.1
  • 158
    • 79955902798 scopus 로고    scopus 로고
    • Genetics of antipsychotic-induced side effects and agranulocytosis
    • Chowdhury NI, Remington G, Kennedy JL. Genetics of antipsychotic-induced side effects and agranulocytosis. Curr Psychiatry Rep 2011; 13: 156-165.
    • (2011) Curr Psychiatry Rep , vol.13 , pp. 156-165
    • Chowdhury, N.I.1    Remington, G.2    Kennedy, J.L.3
  • 159
    • 56449127168 scopus 로고    scopus 로고
    • Performance of a neuro-fuzzy model in predicting weight changes of chronic schizophrenic patients exposed to antipsychotics
    • Lan TH, Loh EW, Wu MS, Hu TM, Chou P, Lan TY et al. Performance of a neuro-fuzzy model in predicting weight changes of chronic schizophrenic patients exposed to antipsychotics. Mol Psychiatry 2008; 13: 1129-1137.
    • (2008) Mol Psychiatry , vol.13 , pp. 1129-1137
    • Lan, T.H.1    Loh, E.W.2    Wu, M.S.3    Hu, T.M.4    Chou, P.5    Lan, T.Y.6
  • 160
    • 64749101027 scopus 로고    scopus 로고
    • Weight effects associated with antipsychotics: A comprehensive database analysis
    • Parsons B, Allison DB, Loebel A, Williams K, Giller E, Romano S et al. Weight effects associated with antipsychotics: a comprehensive database analysis. Schizophr Res 2009; 110: 103-110.
    • (2009) Schizophr Res , vol.110 , pp. 103-110
    • Parsons, B.1    Allison, D.B.2    Loebel, A.3    Williams, K.4    Giller, E.5    Romano, S.6
  • 163
    • 36849066949 scopus 로고    scopus 로고
    • Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants
    • DOI 10.1016/j.schres.2007.09.030, PII S0920996407004379
    • Ellingrod VL, Miller DD, Taylor SF, Moline J, Holman T, Kerr J. Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Schizophr Res 2008; 98: 47-54. (Pubitemid 350235903)
    • (2008) Schizophrenia Research , vol.98 , Issue.1-3 , pp. 47-54
    • Ellingrod, V.L.1    Miller, D.D.2    Taylor, S.F.3    Moline, J.4    Holman, T.5    Kerr, J.6
  • 164
    • 70349464940 scopus 로고    scopus 로고
    • The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia
    • Herken H, Erdal M, Aydin N, Sengul C, Karadag F, Barlas O et al. The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia. DNA Cell Biol 2009; 28: 515-519.
    • (2009) DNA Cell Biol , vol.28 , pp. 515-519
    • Herken, H.1    Erdal, M.2    Aydin, N.3    Sengul, C.4    Karadag, F.5    Barlas, O.6
  • 165
    • 34548760167 scopus 로고    scopus 로고
    • Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients
    • DOI 10.1177/0269881106072750
    • Bozina N, Medved V, Kuzman MR, Sain I, Sertic J. Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients. J Psychopharmacol 2007; 21: 728-734. (Pubitemid 47437910)
    • (2007) Journal of Psychopharmacology , vol.21 , Issue.7 , pp. 728-734
    • Bozina, N.1    Medved, V.2    Kuzman, M.R.3    Sain, I.4    Sertic, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.